Skip to content
Open access · CC-BY via OpenAlex

Aging and Neurodegenerative Disease: Is the Adaptive Immune System a Friend or Foe?

Katie Mayne, Jessica A. White, Christopher E McMurran, Francisco J. Rivera, Alerie Guzman de la Fuente

Frontiers in Aging Neuroscience · 2020 · ▲ 166 citations

Abstract

Neurodegenerative diseases of the central nervous system (CNS) are characterized by progressive neuronal death and neurological dysfunction, leading to increased disability and a loss of cognitive or motor functions. Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis have neurodegeneration as a primary feature. However, in other CNS diseases such as multiple sclerosis, stroke, traumatic brain injury, and spinal cord injury, neurodegeneration follows another insult, such as demyelination or ischaemia. Although there are different primary causes to these diseases, they all share a hallmark of neuroinflammation. Neuroinflammation can occur through the activation of resident immune cells such as microglia, cells of the innate and adaptive peripheral immune system, meningeal inflammation and autoantibodies directed toward components of the CNS. Despite chronic inflammation being pathogenic in these diseases, local inflammation after insult can also promote endogenous regenerative processes in the CNS, which are key to slowing disease progression. The normal aging process in the healthy brain is associated with a decline in physiological function, a steady increase in levels of neuroinflammation, brain shrinkage, and memory deficits. Likewise, aging is also a key contributor to the progression and exacerbation of neurodegenerative diseases. As there are associated co-morbidities within an aging population, pinpointing the precise relationship between aging and neurodegenerative disease progression can be a challenge. The CNS has historically been considered an isolated, "immune privileged" site, however, there is mounting evidence that adaptive immune cells are present in the CNS of both healthy individuals and diseased patients. Adaptive immune cells have also been implicated in both the degeneration and regeneration of the CNS. In this review, we will discuss the key role of the adaptive immune system in CNS degeneration and regeneration, with a focus on how aging influences this crosstalk.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3389/fnagi.2020.572090
Canonical
link ↗
Fetched
2026-10-17 MST

Cite this

APA
Mayne, K., White, J.A., McMurran, C.E., Rivera, F.J., &amp; Fuente, A.G.D.L. (2020). Aging and Neurodegenerative Disease: Is the Adaptive Immune System a Friend or Foe?. <em>Frontiers in Aging Neuroscience</em>. https://doi.org/10.3389/fnagi.2020.572090
Vancouver
Mayne K, White JA, McMurran CE, Rivera FJ, Fuente AGDL. Aging and Neurodegenerative Disease: Is the Adaptive Immune System a Friend or Foe?. Frontiers in Aging Neuroscience. 2020. doi:10.3389/fnagi.2020.572090.
BibTeX
@article{katie2020Aginga, title = {Aging and Neurodegenerative Disease: Is the Adaptive Immune System a Friend or Foe?}, author = {Katie Mayne and Jessica A. White and Christopher E McMurran and Francisco J. Rivera and Alerie Guzman de la Fuente}, journal = {Frontiers in Aging Neuroscience}, year = {2020}, doi = {10.3389/fnagi.2020.572090}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings